🇺🇸 DPP-4 inhibitor in United States

DPP-4 inhibitor (DPP-4 inhibitor) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

DPP-4 inhibitor in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DPP-4 inhibitor approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for DPP-4 inhibitor in United States?

Brigham and Women's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.